Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W D Fraser

Showing results (161-170 of 242) with videos related to

Pageof 25
Sort By:
Bone|March 14, 2003
Parathyroid hormone secretory pattern, circulating activity, and effect on bone turnover in adult growth hormone deficiencyA M Ahmad, M T Hopkins, W D Fraser, et al.
The Journal of Clinical Endocrinology and Metabolism|January 22, 2011
Effect of oral phosphate and alendronate on bone mineral density when given as adjunctive therapy to growth hormone replacement in adult growth hormone deficiencyH D White, A M Ahmad, B H Durham, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 1, 1989
Contrasting mechanisms of hypercalcemia in patients with early and advanced humoral hypercalcemia of malignancyS H Ralston, B F Boyce, R A Cowan, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 17, 2017
Longevity of daily oral vitamin D3 supplementation: differences in 25OHD and 24,25(OH)2D observed 2 years after cessation of a 1-year randomised controlled trial (VICtORy RECALL)H M Macdonald, A Gryka, J C Y Tang, et al.
Blood|October 7, 2000
Biochemical markers of bone turnover following high-dose chemotherapy and autografting in multiple myelomaR E Clark, A J Flory, E M Ion, et al.
Calcified Tissue International|July 16, 2008
Parathyroid hormone(1-84) treatment of postmenopausal women with low bone mass receiving hormone replacement therapyI Fogelman, J N Fordham, W D Fraser, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 8, 2006
Association of PLOD1 polymorphisms with bone mineral density in a population-based study of women from the UKP N Tasker, H Macdonald, W D Fraser, et al.
Bone|September 30, 2004
Methylenetetrahydrofolate reductase polymorphism interacts with riboflavin intake to influence bone mineral densityH M Macdonald, F E McGuigan, W D Fraser, et al.
Annals of Clinical Biochemistry|September 5, 2009
Acidification and urine calcium: is it a preanalytical necessity?R Sodi, L B Bailey, J Glaysher, et al.
Annals of Clinical Biochemistry|April 16, 2010
Correlation of serum-adjusted calcium with ionized calcium over a 24-h period in patients with adult growth hormone deficiency before and after growth hormone replacementHelen D White, A A Joshi, A M Ahmad, et al.
Pageof 25

Showing results (161-170 of 242) with videos related to

Sort By:
Pageof 25
Bone|March 14, 2003
Parathyroid hormone secretory pattern, circulating activity, and effect on bone turnover in adult growth hormone deficiencyA M Ahmad, M T Hopkins, W D Fraser, et al.
The Journal of Clinical Endocrinology and Metabolism|January 22, 2011
Effect of oral phosphate and alendronate on bone mineral density when given as adjunctive therapy to growth hormone replacement in adult growth hormone deficiencyH D White, A M Ahmad, B H Durham, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 1, 1989
Contrasting mechanisms of hypercalcemia in patients with early and advanced humoral hypercalcemia of malignancyS H Ralston, B F Boyce, R A Cowan, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 17, 2017
Longevity of daily oral vitamin D3 supplementation: differences in 25OHD and 24,25(OH)2D observed 2 years after cessation of a 1-year randomised controlled trial (VICtORy RECALL)H M Macdonald, A Gryka, J C Y Tang, et al.
Blood|October 7, 2000
Biochemical markers of bone turnover following high-dose chemotherapy and autografting in multiple myelomaR E Clark, A J Flory, E M Ion, et al.
Calcified Tissue International|July 16, 2008
Parathyroid hormone(1-84) treatment of postmenopausal women with low bone mass receiving hormone replacement therapyI Fogelman, J N Fordham, W D Fraser, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 8, 2006
Association of PLOD1 polymorphisms with bone mineral density in a population-based study of women from the UKP N Tasker, H Macdonald, W D Fraser, et al.
Bone|September 30, 2004
Methylenetetrahydrofolate reductase polymorphism interacts with riboflavin intake to influence bone mineral densityH M Macdonald, F E McGuigan, W D Fraser, et al.
Annals of Clinical Biochemistry|September 5, 2009
Acidification and urine calcium: is it a preanalytical necessity?R Sodi, L B Bailey, J Glaysher, et al.
Annals of Clinical Biochemistry|April 16, 2010
Correlation of serum-adjusted calcium with ionized calcium over a 24-h period in patients with adult growth hormone deficiency before and after growth hormone replacementHelen D White, A A Joshi, A M Ahmad, et al.
Pageof 25